Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Talpaz

Showing results (131-140 of 350) with videos related to

Pageof 35
Sort By:
American Journal of Hematology|April 1, 1987
Clinical and laboratory changes induced by alpha interferon in chronic lymphocytic leukemia--a pilot studyM Talpaz, M Rosenblum, R Kurzrock, et al.
Blood|April 21, 2001
Down-regulation of interleukin-3/granulocyte-macrophage colony-stimulating factor receptor beta-chain in BCR-ABL(+) human leukemic cells: association with loss of cytokine-mediated Stat-5 activation and protection from apoptosis after BCR-ABL inhibitionN J Donato, J Y Wu, L Zhang, et al.
Blood|May 1, 1995
Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: lack of correlation with prognosisJ E Cortes, M Talpaz, F Cabanillas, et al.
Cancer|October 1, 1991
Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemiaP J Schilling, R Kurzrock, H Kantarjian, et al.
Blood|January 15, 1990
Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: a chronic myeloid leukemia with a distinct clinical courseR Kurzrock, H M Kantarjian, M Shtalrid, et al.
Hematologic Pathology|January 1, 1987
The effect of long-term marrow culture on the nonadherent Philadelphia chromosome-positive clone in chronic myelogenous leukemia: preliminary observationsS O'Brien, H M Kantarjian, M Talpaz, et al.
Leukemia|September 20, 2000
Autoantibodies to Abl and Bcr proteinsM Talpaz, X Qiu, K Cheng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Immune-mediated and unusual complications during interferon alfa therapy in chronic myelogenous leukemiaS Sacchi, H Kantarjian, S O'Brien, et al.
Cancer|February 1, 1987
Therapy of chronic myelogenous leukemiaM Talpaz, H Kantarjian, K McCredie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2001
Pilot study of low-dose interleukin-11 in patients with bone marrow failureR Kurzrock, J Cortes, D A Thomas, et al.
Pageof 35

Showing results (131-140 of 350) with videos related to

Sort By:
Pageof 35
American Journal of Hematology|April 1, 1987
Clinical and laboratory changes induced by alpha interferon in chronic lymphocytic leukemia--a pilot studyM Talpaz, M Rosenblum, R Kurzrock, et al.
Blood|April 21, 2001
Down-regulation of interleukin-3/granulocyte-macrophage colony-stimulating factor receptor beta-chain in BCR-ABL(+) human leukemic cells: association with loss of cytokine-mediated Stat-5 activation and protection from apoptosis after BCR-ABL inhibitionN J Donato, J Y Wu, L Zhang, et al.
Blood|May 1, 1995
Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: lack of correlation with prognosisJ E Cortes, M Talpaz, F Cabanillas, et al.
Cancer|October 1, 1991
Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemiaP J Schilling, R Kurzrock, H Kantarjian, et al.
Blood|January 15, 1990
Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: a chronic myeloid leukemia with a distinct clinical courseR Kurzrock, H M Kantarjian, M Shtalrid, et al.
Hematologic Pathology|January 1, 1987
The effect of long-term marrow culture on the nonadherent Philadelphia chromosome-positive clone in chronic myelogenous leukemia: preliminary observationsS O'Brien, H M Kantarjian, M Talpaz, et al.
Leukemia|September 20, 2000
Autoantibodies to Abl and Bcr proteinsM Talpaz, X Qiu, K Cheng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Immune-mediated and unusual complications during interferon alfa therapy in chronic myelogenous leukemiaS Sacchi, H Kantarjian, S O'Brien, et al.
Cancer|February 1, 1987
Therapy of chronic myelogenous leukemiaM Talpaz, H Kantarjian, K McCredie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2001
Pilot study of low-dose interleukin-11 in patients with bone marrow failureR Kurzrock, J Cortes, D A Thomas, et al.
Pageof 35